A*varied issue this week with high-profile reports about the anti-obesity drug rimonabant and widespread coverage about a perennial favourite, homeopathy.* First, a*research article in the form of a meta-analysis reassesses the efficacy and safety of the anti-obesity drug rimonabant. This drug is licenced in many European countries, though not in the USA. Investigators from the University [...]
More...